News
01-30-2012, 08:00 AM
Circadian Technologies Limited announced today the publication of data in the scientific journal, Investigative Ophthalmology & Visual Science (IOVS), showing that VEGF-C expression is markedly up-regulated in corneal graft rejection.
More... (http://www.news-medical.net/news/20120130/Circadians-VGX-100-human-antibody-improves-corneal-graft-survival.aspx)
More... (http://www.news-medical.net/news/20120130/Circadians-VGX-100-human-antibody-improves-corneal-graft-survival.aspx)